Bulevirtide TFA
规格
| Cas Number | 2012558-47-1(free) |
| 规格或纯度 | Moligand™, ≥98% |
| 级别 | Moligand™ |
| 纯度 | ≥98% |
| 包装 | 10mg 或 1mg 或 5mg |
产品信息
| 品牌 | 阿拉丁 |
| 溶解性 | DMSO : 50 mg/mL (9.26 mM; Need ultrasonic) |
| 过滤标签 | HBV,Anti-infection |
| 储存温度 | 避光,-20°C储存,充氩 |
| 运输条件 | 超低温冰袋运输 |
| 物理形态 | 固体 |
| 生化和生理学机理 | 布来韦肽（Myrcludex B）是一种 NTCP 抑制剂，是由 47 个氨基酸组成的线性脂肽。布来韦肽可抑制 HBV 和 HDV 进入肝细胞，阻止 HBV 感染肝细胞，并参与 HBV 转录抑制。布来韦肽可 |
| 描述 |
序列： {Myr}-Gly-Thr-Asn-Leu-Ser-Val-Pro-Asn-Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro-Asn-Lys-Asp-His-Trp-Pro-Glu-Ala-Asn-Lys-Val-Gly-NH2 |
| 英文描述 |
Bulevirtide (Myrcludex B) is a NTCP inhibitor, a linear lipopeptide of 47 amino acids. Bulevirtide inhibits HBV and HDV entry into liver cells, blocks HBV infection in hepatocytes, and participates in HBV transcriptional suppression. Bulevirtide can be used in HDV infection and compensated cirrhosis research. Form:Solid |